Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.

Behrendt, Carolyn E; Villalona-Calero, Miguel A; Newman, Edward M; Frankel, Paul H

Behrendt, Carolyn E; Villalona-Calero, Miguel A; Newman, Edward M; Frankel, Paul H.

Afiliación

Behrendt CE; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: CarolynBehrendt77@gmail.com.
Villalona-Calero MA; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: mvillalona@coh.org.
Newman EM; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: edwardmnewman@gmail.com.
Frankel PH; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: pfrankel@coh.org.

Contemp Clin Trials ; 125: 107083, 2023 02.

Article en En | MEDLINE | ID: mdl-36638911

Asunto(s)

Carcinoma de Células Renales; Ensayos Clínicos Fase II como Asunto; Selección de Paciente; Trasplante de Células Madre; Humanos; Carcinoma de Células Renales/terapia

Palabras clave

Disease progression; Early discontinuation; Entry rank; Phase II trials; Survival; Toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Ensayos Clínicos Fase II como Asunto / Selección de Paciente / Trasplante de Células Madre Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google